Vagal stimulation in heart failure

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.

Original languageEnglish
Pages (from-to)310-320
Number of pages11
JournalJournal of Cardiovascular Translational Research
Volume7
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Heart Failure
Stroke Volume
Quality of Life
Safety
Survival
Clinical Studies
Walk Test

Keywords

  • Anti-inflammatory activity
  • Heart failure
  • Reperfusion damage
  • Vagal activity
  • Vagus nerve stimulation
  • Ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics
  • Genetics(clinical)
  • Molecular Medicine
  • Pharmaceutical Science
  • Medicine(all)

Cite this

Vagal stimulation in heart failure. / De Ferrari, Gaetano M.

In: Journal of Cardiovascular Translational Research, Vol. 7, No. 3, 2014, p. 310-320.

Research output: Contribution to journalArticle

@article{0889600d3ee84c11b1479837af40a23b,
title = "Vagal stimulation in heart failure",
abstract = "Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.",
keywords = "Anti-inflammatory activity, Heart failure, Reperfusion damage, Vagal activity, Vagus nerve stimulation, Ventricular fibrillation",
author = "{De Ferrari}, {Gaetano M.}",
year = "2014",
doi = "10.1007/s12265-014-9540-1",
language = "English",
volume = "7",
pages = "310--320",
journal = "Journal of Cardiovascular Translational Research",
issn = "1937-5387",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Vagal stimulation in heart failure

AU - De Ferrari, Gaetano M.

PY - 2014

Y1 - 2014

N2 - Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.

AB - Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.

KW - Anti-inflammatory activity

KW - Heart failure

KW - Reperfusion damage

KW - Vagal activity

KW - Vagus nerve stimulation

KW - Ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84899445722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899445722&partnerID=8YFLogxK

U2 - 10.1007/s12265-014-9540-1

DO - 10.1007/s12265-014-9540-1

M3 - Article

C2 - 24500409

AN - SCOPUS:84899445722

VL - 7

SP - 310

EP - 320

JO - Journal of Cardiovascular Translational Research

JF - Journal of Cardiovascular Translational Research

SN - 1937-5387

IS - 3

ER -